Search Tag: #ESCCongress2024

2024 01 Sep

  A pooled analysis of three major trials presented at #ESCCongress2024  did not show significant reductions in cardiovascular death with finerenone. However, significant decreases in all-cause mortality, cardiovascular events, and kidney outcomes were observed.    Cardiovascular diseases, chronic kidney disease (CKD), and metabolic conditions...Read more

2024 01 Sep

  Adherence to atrial fibrillation (AF) guideline recommendations in clinical practice across Europe was found to be poor, but a structured educational programme for healthcare professionals significantly improved the implementation of heart rhythm control recommendations, according to research presented in a Hot Line session at the ESC Congress...Read more